01 November 2017 10 3K Report

Epidemiological and basic science evidence suggests a possible shared pathophysiology between type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD). It has even been hypothesized that AD might be ‘type 3 diabetes’. The present review summarizes some of the evidence for the possible link, putative biochemical pathways and ongoing clinical trials of anti-diabetic drugs in AD patients.

More Ogail Dawod's questions See All
Similar questions and discussions